Cleveland, OH, United States of America

Paul Resendes

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Parker-Hannifin Corporation, The Cleveland Clinic Foundation. Active years: 2021-2025.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Paul Resendes: Innovator in Fluid Delivery Systems

Introduction

Paul Resendes is a notable inventor based in Cleveland, OH (US). He has made significant contributions to the field of fluid delivery systems, holding a total of 4 patents. His work focuses on creating efficient and effective solutions for dispensing purified and sterilized fluids.

Latest Patents

One of Paul Resendes' latest patents is a sterile and/or purified fluid and/or solution delivery system. This innovative system includes a fluid reservoir, a sterilization and/or purification mechanism, a solution production mechanism, a dispensing mechanism, and a controller. The system is designed to dispense purified and sterilized fluid and/or solution on-demand, showcasing his commitment to advancing healthcare technology.

Career Highlights

Throughout his career, Paul has worked with prominent organizations such as Parker-Hannifin Corporation and The Cleveland Clinic Foundation. His experience in these institutions has allowed him to develop and refine his inventions, contributing to advancements in medical technology.

Collaborations

Paul has collaborated with talented individuals in his field, including Joseph Foss and Gino Banco. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Paul Resendes is a distinguished inventor whose work in fluid delivery systems has made a significant impact in the medical field. His innovative solutions continue to enhance the efficiency of fluid dispensing, ultimately benefiting healthcare providers and patients alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…